So, Who Will Replace Marjorie Taylor Greene in Georgia?
So, the White House Just Released Numbers on Trump's Tax Cuts. What They...
Wait, Mamdani Got Cozy With Another Terrorist at a Public Event. The Gracie...
Fani Willis Wants to Fight Trump on Recouping Legal Fees. This Is What the...
New Poll Could Show Who's Leading In the Texas Republican Senate Primary
Tennessee Bill Would Place Foster Children In Detention Even If They Haven't Been...
Tim Walz, the Biggest Fraudster of Them All
Chicago Kids Can't Read, but Their Teachers Can Protest for Iran
Left-Wing Activists Are Training Juries to Sabotage Trump DOJ Cases
Deconstructing the Latest Epstein Mania
Senator Tom Cotton Draws a Line Between True Conservatives and Antisemitic Influencers
Steve Witkoff Reveals Just How Much Weapons-Grade Uranium Iran Had Before Operation Epic...
Trump Is Bringing Historic Changes to the U.S. Energy Sector
What the NYC ISIS Bombers Had In Their Storage Unit Was Insane
GOP Will Bring SAVE Act to the Floor to 'Put Democrats on the...
Tipsheet

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’
AP Photo/Pablo Martinez Monsivais, File

Speaking during remarks to a J.P. Morgan healthcare conference this week, Pfizer CEO Albert Bourla openly stated current vaccines the company developed for Wuhan coronavirus offer "limited, if any" protection against contracting current variants of the disease. He then encouraged booster shots. 

The statement from Bourla comes as the Biden administration continues to justify vaccine mandates for federal workers, contractors and private businesses. The Supreme Court heard arguments about President Biden's mandates for private companies and medical workers last week. A ruling is expected soon on the constitutionality of the mandates. 

A number of people who have pointed out the waning efficacy of Pfizer's vaccines, which Bourla touted last year as being "100 percent" effective against contracting or transmitting the virus, have been banned by social media companies. 

Meanwhile, Bourla also announced this week the company is developing a vaccine specific to Omicron. It is expected to be ready in March when health officials predict the latest wave of the mild variant will already be over. 

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos